Patent · US Expired

EP4 receptor antagonists

US7417068B2 · kind B2 · utility

5Cited by
28References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 15, 2004
Grant dateAug 26, 2008
Priority date—
Expiry dateNov 12, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of formula (I):or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: wherein R is optionally substituted C1-7 alkyl, C5-20 aryl, or NRN3RN4, where RN3 and RN4 are independently selected from optionally substituted C1-4 alkyl; or

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.